Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6892922

CNC(=O)CC(N)=O.O=C(O)C(F)(F)F

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CHIT1 Q13231 14/20 0.40
NOS1 P29475 1/20 0.33
NOS2 P35228 1/20 0.33
MCL1 Q07820 1/20 0.32
LMNA P02545 1/20 0.32
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL410254 0.83
Trifluoroacetic Acid SCHEMBL6885600 0.81 NOS1 (0.35) CHIT1NOS1NOS2LMNAKMT2A
Trifluoroacetic Acid SCHEMBL6221198 0.80 CHIT1 (0.38) CHIT1MCL1LMNA
Trifluoroacetic Acid SCHEMBL29695879 0.79 CHIT1 (0.38) CHIT1NOS1NOS2LMNA
Trifluoroacetic Acid SCHEMBL28148714 0.77 MEN1 (0.36) CHIT1MCL1LMNAKMT2A
Trifluoroacetic Acid SCHEMBL4276694 0.76 CHIT1 (0.35) CHIT1NOS1NOS2
Trifluoroacetic Acid SCHEMBL3723315 0.75 CHIT1 (0.36) CHIT1NOS1NOS2
Trifluoroacetic Acid SCHEMBL3241512 0.74 FFAR3 (0.40) NOS1NOS2KMT2A
Trifluoroacetic Acid SCHEMBL20527407 0.74 FFAR3 (0.40) NOS1NOS2KMT2A
Trifluoroacetic Acid SCHEMBL29921797 0.74 FFAR3 (0.40) NOS1NOS2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6794365-B2 INHIBITORS OF THE BLOOD CLOTTING ENZYME FACTOR XA; TREATING THROMBOEMBOLIC DISEASES; TRIFLUOROACETIC ACID SALT OF 2-(4-CARBAMIMIDOYL-BENZYL)-N-((1-CARBAMOYL-4-GUANIDINO-BUTYLCARBAMOYL) -CYCLOHEXYL-METHYL)-N',N'-DIMETHYL-MALONAMIDE AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2004-09-21 US disclosed
US-6395737-B1 ANTICOAGULANTS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2002-05-28 US disclosed